Skip to main content
Richard Whitley, MD, Pediatric Infectious Disease, Birmingham, AL

Richard J Whitley MD


Professor, Pediatrics, University of Alabama School of Medicine

Join to view full profile
  • 1600 6th Ave SSte 303Birmingham, AL 35233

  • Phone+1 205-638-9181

Dr. Whitley is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Distinguished Professor of Pediatrics
    Loeb Professor
    Professor of Pediatrics, Microbiology, Medicine, and Neurosurgery

Education & Training

  • University of Alabama Hospital (Birmingham)
    University of Alabama Hospital (Birmingham)Residency, Pediatrics, 1971 - 1975
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 1971

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1973 - 2026
  • Pediatrics
    American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Elected Member Association of American Physicians, 2010
  • Elected Member The American Society for Clinical Investigation, 1989
  • Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • IDBR Infectious Disease Board Review Course 
    George Washington University, Mclean, Virginia - 8/24/2013

Press Mentions

  • Altesa BioSciences Announces Scientific Advisory Board
    Altesa BioSciences Announces Scientific Advisory BoardFebruary 28th, 2022
  • Merck's COVID Pill Shows 'Modest' Benefit in High-Risk Outpatients
    Merck's COVID Pill Shows 'Modest' Benefit in High-Risk OutpatientsDecember 16th, 2021
  • There Are Few Good COVID Antivirals, but That Could Be Changing
    There Are Few Good COVID Antivirals, but That Could Be ChangingJuly 15th, 2021

Grant Support

  • Antiviral Drug Discovery and Development Center (AD3C)UNIVERSITY OF ALABAMA AT BIRMINGHAM2019–2025
  • Preclinical Evaluation Of Oncolytic HSV For Anaplastic Glioma TherapyNational Cancer Institute2009–2011
  • Engineered HSV For Treatment Of Malignant GliomaNational Cancer Institute2009–2011
  • Administrative CoreNational Cancer Institute2009–2011
  • Development Of Antiviral Screens And Animal ModelsNational Institute Of Allergy And Infectious Diseases2008

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: